The Clinical Trial Market in the United Kingdom is expected to register a CAGR of 4.7% over the forecast period from 2024 to 2034. AI, machine learning, and blockchain are set to transform the clinical trials landscape NEWARK, Del.
, July 10, 2024 /PRNewswire/ -- The landscape of medical discovery is on track for continued expansion. The global Clinical Trial Market Size , valued at USD 120.97 billion in 2024, is projected to reach a substantial USD 184.
61 billion by 2034. This signifies a steady growth trajectory, with a CAGR (Compound Annual Growth Rate) of 4.3%.
Both governmental and private sponsorship of clinical trials is helping them increase in number. As the number of diseases and patients increases, there is more demand for research to come up with newer medicines and treatments. The rise in cancer patients is especially necessitating the development of more oncology clinical trials.
Clinical trials are making use of advanced technology like AI and machine learning. These technologies are helping researchers handle data, select better samples, save time, and increase effectiveness. Technology is also allowing researchers conduct virtual trials, a holdover from the pandemic era that is still going strong.
Request a Sample Copy of this Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-384 There are, however, impediments to market growth.
While more people are open to being a part of trials, sometimes researchers struggle to find the right candidates w.
